American Century Companies Inc. Reduces Stake in Axcelis Technologies, Inc. $ACLS

American Century Companies Inc. lessened its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 18.9% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,345,761 shares of the semiconductor company’s stock after selling 313,702 shares during the quarter. American Century Companies Inc. owned 4.34% of Axcelis Technologies worth $131,400,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. LSV Asset Management bought a new stake in shares of Axcelis Technologies during the 3rd quarter valued at about $30,747,000. Boston Partners lifted its stake in shares of Axcelis Technologies by 42.3% in the 2nd quarter. Boston Partners now owns 474,043 shares of the semiconductor company’s stock worth $33,616,000 after purchasing an additional 141,004 shares during the period. Allspring Global Investments Holdings LLC boosted its holdings in shares of Axcelis Technologies by 1,344.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 109,628 shares of the semiconductor company’s stock worth $10,388,000 after buying an additional 102,040 shares during the last quarter. Reinhart Partners LLC. grew its position in Axcelis Technologies by 6.0% during the third quarter. Reinhart Partners LLC. now owns 1,610,332 shares of the semiconductor company’s stock valued at $157,234,000 after buying an additional 91,788 shares during the period. Finally, Balyasny Asset Management L.P. bought a new stake in Axcelis Technologies during the second quarter valued at approximately $6,324,000. Institutional investors own 89.98% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axcelis Technologies in a research report on Monday, December 22nd. B. Riley Financial reduced their price objective on Axcelis Technologies from $94.00 to $91.00 and set a “neutral” rating for the company in a research note on Wednesday, February 18th. Zacks Research cut Axcelis Technologies from a “hold” rating to a “strong sell” rating in a report on Friday, February 20th. Wall Street Zen downgraded Axcelis Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, January 3rd. Finally, Bank of America boosted their price target on Axcelis Technologies from $90.00 to $100.00 and gave the company an “underperform” rating in a report on Tuesday, January 13th. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $101.50.

Insider Activity

In other news, EVP Gerald M. Blumenstock sold 3,034 shares of the firm’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $89.46, for a total transaction of $271,421.64. Following the completion of the transaction, the executive vice president owned 18,661 shares in the company, valued at $1,669,413.06. This trade represents a 13.98% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jorge Titinger sold 2,000 shares of Axcelis Technologies stock in a transaction dated Wednesday, December 17th. The stock was sold at an average price of $86.05, for a total value of $172,100.00. Following the completion of the sale, the director directly owned 7,477 shares in the company, valued at $643,395.85. This trade represents a 21.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 6,034 shares of company stock valued at $523,522 in the last three months. Insiders own 0.48% of the company’s stock.

Axcelis Technologies Trading Down 1.2%

ACLS stock opened at $82.61 on Monday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.77 and a quick ratio of 3.11. Axcelis Technologies, Inc. has a 1-year low of $40.40 and a 1-year high of $102.93. The business has a 50 day simple moving average of $87.80 and a two-hundred day simple moving average of $85.82. The company has a market capitalization of $2.54 billion, a price-to-earnings ratio of 21.80, a PEG ratio of 9.88 and a beta of 1.78.

Axcelis Technologies (NASDAQ:ACLS) last released its earnings results on Tuesday, February 17th. The semiconductor company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.12 by $0.37. Axcelis Technologies had a net margin of 14.33% and a return on equity of 13.73%. The firm had revenue of $238.33 million for the quarter, compared to the consensus estimate of $215.04 million. During the same quarter in the previous year, the firm earned $1.54 earnings per share. The company’s quarterly revenue was down 5.6% compared to the same quarter last year. Axcelis Technologies has set its Q1 2026 guidance at 0.710-0.710 EPS. Research analysts anticipate that Axcelis Technologies, Inc. will post 2.55 EPS for the current fiscal year.

Axcelis Technologies Profile

Axcelis Technologies, Inc is a leading developer and manufacturer of ion implantation and cleaning equipment used in the fabrication of semiconductor chips. The company specializes in high-current, medium-current and high-energy ion implantation systems, which are critical for introducing precisely controlled dopants into silicon wafers. Axcelis also offers plasma-based cleaning and dry strip tools that support advanced process nodes in logic, memory and power device manufacturing.

The company’s product portfolio encompasses single-wafer and multi-wafer cluster tools designed to deliver high throughput, accuracy and uniformity for semiconductor process steps.